Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aftin-4 is an experimental small molecule belonging to the class of 6‑alkylaminopurines. Its chemical structure features a purine core substituted with benzyl(methyl)amino and isopropyl groups, as well as a butanol side chain. There is limited publicly available information on its mechanism of action, biological targets, or therapeutic indications. It has been cataloged in drug databases for research purposes but does not have established clinical use or known pharmacological activity[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aftin-4.